Clinical Trial Update: The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial is investigating intravenous amantadine for freezing of gait in Parkinson's disease patients resistant to dopaminergic therapy; the status is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Freezing of Gait
• Parkinson Disease

Drugs mentioned

• amantadine (amantadine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Parkinson's Disease, Freezing of Gait | Phase 4 | Status: UNKNOWN